Clinical Trial Update: Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Shenqi Sherong Pill for Cervical Spondylotic Myelopathy has completed. The update reports efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Spondylotic Myelopathy

Drugs mentioned

• Shenqi Sherong Pill

Snippet

Sponsor: Shanghai Hutchison Pharmaceuticals Limited | Conditions: Cervical Spondylotic Myelopathy | Phase 3 | Status: COMPLETED